Early detection of pancreatic cancer goal for newly initiated EU project


Masood Kamali-Mogahaddam at IGP is part of an international consortium that aims to develop a blood test for early detection of pancreatic cancer. Earlier in February, all partners met in Hamburg for a kick-off.

Pancreatic cancer usually shows vague symptoms and is often discovered at a late stage. Therefore, most patients die within one year after diagnosis. This makes it incredibly important to develop methods to detect and diagnose the disease at an early stage.

In the EU-funded project PANCAID, the researchers aim to develop a blood test that can be used for early detection of pancreatic cancer and its precursor lesions. The technologies for studying extracellular vesicles developed by Kamali’s team will be used to analyse blood samples and identify potential biomarkers.

The project was initiated in January this year and includes seventeen partners from eight countries. It is part of the EU programme Mission: Cancer and has received funding of Euro 9.8 million for five years.

More information:

News item SciLifeLab

PANCAID’s web site

Participants at the kick-off, lined up for being photograp
PANCAID partners at the project’s kick-off in Hamburg on 13 – 15 February.